Clinical trial support companies are rapidly adopting AI, but sponsors have been more hesitant. Raj Indupuri, CEO of eClinical Solutions, gives the top three reasons behind the holdup in AI agent deployment. He explains the specific pattern of uptake for these agents, the required human-in-the-loop oversight, and how the agents can improve clinical trial velocity. Host Deborah Borfitz also gives the latest news on a highly acclaimed treatment for pancreatic cancer, filling evidence gaps in dr...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The Scope of Things
Episode: 51 - Bridging the Equity Gap in Oncology with Eugene Manley, Jr.
Episode: 50 - Ramona Burress and Cassandra O’Neal on Health Equity That Works
Episode: 49 - Mike Sullivan on AI and Clinical Operations in the Year 2030
Episode: 48 - Florence Mowlem on the Challenges and Solutions of Pediatric Rare Disease Trials
Get summaries like this every morning.
Free AI-powered recaps of The Scope of Things and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.